Bernie Sanders on money-in-politics: what the evidence says · JRE #1330
“Over the last 20 years, the drug companies alone have spent $4.5 billion in 20 years on lobbying and campaign contributions.”
What the evidence says
Sanders' claim that drug companies spent "$4.5 billion...on lobbying and campaign contributions" over 20 years blurs two distinct funding streams into a single figure. Federal lobbying-disclosure data compiled by OpenSecrets shows pharmaceuticals/health products was consistently the top-spending lobbying industry, with cumulative lobbying expenditures in the multi-billion-dollar range over the two decades in question, so the $4.5 billion figure appears to describe lobbying spending alone rather than lobbying plus contributions combined. Campaign contributions from the industry are tracked separately by OpenSecrets and are far smaller: in a later public statement, Sanders himself separated the two categories explicitly, citing $8.5 billion in industry lobbying versus just over $700 million in campaign contributions over a comparable 25-year span, a roughly 12-to-1 ratio that shows lobbying and contributions are normally reported as distinct, unequal sums rather than combined into one total. PolitiFact's review of a related Sanders claim about pharmaceutical lobbying confirmed the industry's lobbying spending was genuinely the largest of any sector, while rating a related lobbyist-count claim only "Half True" for imprecision. The underlying scale of pharmaceutical influence spending is well documented and substantial, but combining lobbying and campaign-contribution totals into a single figure, as this quote does, overstates precision and conflates two categories Sanders elsewhere reports separately.